Anthelmintic milbemycins and avermectins
AssigneePfizer Inc.
InventorsGeoffrey Harold Baker, Roderick John Dorgan, David Owen Morgan, Peter Robin Shelley, Simon Edward Blanchflower
Life of this patent
Estimating the term…
Loading patent…
AssigneePfizer Inc.
InventorsGeoffrey Harold Baker, Roderick John Dorgan, David Owen Morgan, Peter Robin Shelley, Simon Edward Blanchflower
Estimating the term…
Novel compounds of formula (I): ##STR1## wherein R.sup.1 is hydrogen or optionally protected hydroxy; R.sup.2 is alkoxy, optionally protected hydroxy, oxo or optionally O-substituted oximino; R.sup.3 is hydrogen, optionally protected hydroxy,or a group 4'-(.alpha.-L-oleandrosyl)-.alpha.-L-oleandrosyloxy or .alpha.-L-oleandrosyloxy wherein the terminal hydroxy group is optionally protected; R.sup.4, R.sup.5, R.sup.6 and R.sup.7 are the same or different and each is hydrogen or an organic radical; and R.sup.8 is an optionally substituted amino or imino group such as optionally O-substituted oxyimino, optionally N-substituted hydrazone, or optionally N-substituted semicarbazone; are useful in the treatment of helminthiasis in humans and animals.
A process for preparing a compound of formula (I) ##STR96## wherein R.sup.1 is hydrogen or optionally protected hydroxy;
A process for preparing a compound of formula (I):
Dependencies are inferred from the claim text.